Genital Diseases, Female
Welcome,         Profile    Billing    Logout  
 270 Companies   374 Products   374 Products   160 Mechanisms of Action   39 Trials   5519 News 


«12345678910111213...110111»
  • ||||||||||  Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date:  Mechanisms of Infertility and Hormonal Changes in Patients With Chronic Kidney Disease (clinicaltrials.gov) -  Dec 22, 2018   
    P=N/A,  N=0, Withdrawn, 
    N=100 --> 0 | Trial completion date: Aug 2016 --> Aug 2018 | Enrolling by invitation --> Withdrawn | Trial primary completion date: May 2014 --> May 2017
  • ||||||||||  etonogestrel/ethinylestradiol intravaginal ring / Generic mfg.
    Trial completion, Trial completion date, Trial primary completion date:  Effects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local Immunity (clinicaltrials.gov) -  Dec 10, 2018   
    P4,  N=120, Completed, 
    Recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Dec 2018 | Trial primary completion date: Jun 2018 --> Nov 2018
  • ||||||||||  Trial completion:  Assessment of Ovarian Reserve Tests in Unexplained Infertile Women (clinicaltrials.gov) -  Dec 7, 2018   
    P=N/A,  N=80, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Dec 2018 | Trial primary completion date: Jun 2018 --> Nov 2018 Recruiting --> Completed
  • ||||||||||  Trial completion, Trial completion date, Adherence:  Cervical Cancer Screening Among Hispanic Women (clinicaltrials.gov) -  Nov 13, 2018   
    P=N/A,  N=451, Completed, 
    Phase classification: P1 --> P1/2 Active, not recruiting --> Completed | Trial completion date: Jul 2019 --> Jul 2018
  • ||||||||||  Trial completion, Trial completion date, Trial primary completion date:  Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive (clinicaltrials.gov) -  Nov 7, 2018   
    P=N/A,  N=154, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Dec 2019 --> Oct 2018 | Trial primary completion date: Dec 2019 --> Oct 2018
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Role of Metabolomics in the Diagnosis of Endometriosis (clinicaltrials.gov) -  Nov 6, 2018   
    P=N/A,  N=54, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Dec 2019 --> Oct 2018 | Trial primary completion date: Dec 2019 --> Oct 2018 Active, not recruiting --> Completed | N=40 --> 54 | Trial primary completion date: Mar 2016 --> Jun 2016
  • ||||||||||  Enrollment change, Trial initiation date, Trial withdrawal:  Clinical Pregnancy Rate After Removal of Unsuspected Polyps (clinicaltrials.gov) -  Nov 6, 2018   
    P3,  N=0, Withdrawn, 
    Active, not recruiting --> Completed | N=40 --> 54 | Trial primary completion date: Mar 2016 --> Jun 2016 N=200 --> 0 | Initiation date: Dec 2017 --> Jan 2017 | Not yet recruiting --> Withdrawn
  • ||||||||||  Trial completion, Trial completion date, Trial primary completion date:  Phase I Pilot Study to Evaluate the Prognostic Value of Perfusion CT for Primary Cervical Cancer (clinicaltrials.gov) -  Oct 31, 2018   
    P1,  N=24, Completed, 
    N=200 --> 0 | Initiation date: Dec 2017 --> Jan 2017 | Not yet recruiting --> Withdrawn Recruiting --> Completed | Trial completion date: Dec 2019 --> Oct 2018 | Trial primary completion date: Dec 2019 --> Oct 2018
  • ||||||||||  Menopur (menotropin) / Ferring
    Trial completion, Phase classification, Trial completion date, Trial primary completion date:  HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients (clinicaltrials.gov) -  Oct 29, 2018   
    P=N/A,  N=126, Completed, 
    Recruiting --> Completed | Trial completion date: Dec 2019 --> Oct 2018 | Trial primary completion date: Dec 2019 --> Oct 2018 Recruiting --> Completed | Phase classification: P4 --> PN/A | Trial completion date: Jan 2018 --> Apr 2016 | Trial primary completion date: Nov 2017 --> Mar 2016
  • ||||||||||  Trial completion, Phase classification, Trial completion date, Trial primary completion date:  Comparison Between D&C and Hysteroscopy in Management of AUB in Perimenopausal Women (clinicaltrials.gov) -  Oct 29, 2018   
    P=N/A,  N=100, Completed, 
    Recruiting --> Completed | Phase classification: P4 --> PN/A | Trial completion date: Jan 2018 --> Apr 2016 | Trial primary completion date: Nov 2017 --> Mar 2016 Recruiting --> Completed | Phase classification: P4 --> PN/A | Trial completion date: Jul 2017 --> Mar 2018 | Trial primary completion date: Jul 2017 --> Dec 2017
  • ||||||||||  Trial completion:  Platelet Rich Plasma (PRP) for Vulvar Lichen Sclerosus (clinicaltrials.gov) -  Oct 25, 2018   
    P=N/A,  N=29, Completed, 
    Trial primary completion date: Aug 2017 --> Oct 2017 Active, not recruiting --> Completed
  • ||||||||||  dexamethasone / Generic mfg.
    Trial completion:  dexFEM: Dexamethasone for Excessive Menstruation (clinicaltrials.gov) -  Oct 25, 2018   
    P2,  N=123, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed
  • ||||||||||  Trial completion, Trial completion date, Trial primary completion date, Head-to-Head:  SALPINGOVA: Effect of Salpingectomy During Conservative Hysterectomy (clinicaltrials.gov) -  Oct 22, 2018   
    P=N/A,  N=350, Completed, 
    Recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Oct 2018 --> Jun 2018 | Trial primary completion date: Aug 2017 --> May 2017
  • ||||||||||  progesterone / Generic mfg.
    Trial completion, Enrollment change:  Intrauterine Insemination and Luteal Fase Support (clinicaltrials.gov) -  Oct 19, 2018   
    P4,  N=393, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Oct 2018 --> Jun 2018 | Trial primary completion date: Aug 2017 --> May 2017 Enrolling by invitation --> Completed | N=198 --> 393
  • ||||||||||  Enrollment change, Trial completion date, Trial termination, Trial primary completion date:  Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium (clinicaltrials.gov) -  Oct 15, 2018   
    P1,  N=2, Terminated, 
    Recruiting --> Completed N=10 --> 2 | Trial completion date: Nov 2017 --> Apr 2018 | Recruiting --> Terminated | Trial primary completion date: Nov 2017 --> Apr 2018
  • ||||||||||  Trial completion, Trial completion date, Trial primary completion date:  KINVAV: Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix (clinicaltrials.gov) -  Oct 12, 2018   
    P3,  N=327, Completed, 
    N=10 --> 2 | Trial completion date: Nov 2017 --> Apr 2018 | Recruiting --> Terminated | Trial primary completion date: Nov 2017 --> Apr 2018 Recruiting --> Completed | Trial completion date: Oct 2017 --> Aug 2018 | Trial primary completion date: Aug 2017 --> Aug 2018
  • ||||||||||  Trial completion:  Heart Rate Variability Biofeedback for Female Sexual Arousal Disorder (clinicaltrials.gov) -  Oct 11, 2018   
    P=N/A,  N=65, Completed, 
    Recruiting --> Completed | Trial completion date: Oct 2017 --> Aug 2018 | Trial primary completion date: Aug 2017 --> Aug 2018 Recruiting --> Completed
  • ||||||||||  Imfinzi (durvalumab) / AstraZeneca
    Trial completion date, Trial termination:  MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors (clinicaltrials.gov) -  Oct 10, 2018   
    P2,  N=4, Terminated, 
    Recruiting --> Completed | Trial completion date: Jun 2017 --> Apr 2018 | Trial primary completion date: Jun 2017 --> Apr 2018 Trial completion date: Dec 2021 --> Jan 2018 | Active, not recruiting --> Terminated; Low accrual, funding withdrawn by AstraZeneca, and change in clinical practice
  • ||||||||||  Arenegyr (NGR-hTNF) / AGC Biologics
    Trial completion, Trial completion date, Trial primary completion date, Combination therapy:  Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer (clinicaltrials.gov) -  Sep 27, 2018   
    P2,  N=119, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Jun 2017 --> Dec 2016 | Trial primary completion date: Jun 2016 --> Dec 2016
  • ||||||||||  Trial completion, Biopsy:  Optimal Order of Concurrent Office Hysteroscopy and Endometrial Biopsy (clinicaltrials.gov) -  Sep 26, 2018   
    P=N/A,  N=78, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Jun 2017 --> Dec 2016 | Trial primary completion date: Jun 2016 --> Dec 2016 Recruiting --> Completed
  • ||||||||||  Trial completion, Trial completion date:  AMPAMAVIR: Prevalence of HPV Transmission During Medically Assisted Procreation Procedures (clinicaltrials.gov) -  Sep 24, 2018   
    P=N/A,  N=915, Completed, 
    Recruiting --> Completed | N=30 --> 10 | Trial completion date: Aug 2018 --> Mar 2018 Active, not recruiting --> Completed | Trial completion date: Jan 2018 --> Feb 2016
  • ||||||||||  Enrollment change, Trial termination, Trial primary completion date:  Assessment of Performance of [18F]-FES for Endometriosis Diagnosis (clinicaltrials.gov) -  Sep 17, 2018   
    P2,  N=31, Terminated, 
    Recruiting --> Active, not recruiting | Trial completion date: Jun 2018 --> Dec 2018 | Trial primary completion date: Jun 2018 --> Dec 2018 N=100 --> 31 | Recruiting --> Terminated | Trial primary completion date: Oct 2016 --> Apr 2016; not enough enrollement